You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

500 Results
Guidelines and Advice
Status: Current
ID: GL-C50-24
Version: 3
Jan 2024
Guidelines and Advice
Status: Current
ID: GL-C50-32
Jan 2021
Symptom Management
Drug
Other Name(s): Navelbine®
Apr 2023
Drug
Other Name(s): Oncovin® (multiple brands available)
Nov 2017
Drug
Other Name(s): Neulasta® , Lapelga™ , Fulphila™ , Ziextenzo® , Nyvepria™
Dec 2022
Drug
Other Name(s): Alimta®
Apr 2023

Pages